NCT07209033View on ClinicalTrials.gov

FlexiOss® - Efficacy, Safety and Long-term (Radiological and Clinical) Outcomes During Comprehensive Care Continuum of Implanted Biocomposite for Bone Regeneration.

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 29, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
Bone Defect
Interventions
DEVICE

FlexiOss®

Bone reconstruction with FlexiOss® biocomposite.

PROCEDURE

Allogenic human bone grafting

Implantation of allogenic human bone graft.

Trial Locations (1)

05-400

RECRUITING

Klinika Chirurgii Urazowej Narządu Ruchu i Ortopedii CMKP Samodzielny Publiczny Szpital Kliniczny im. prof. Adama Grucy Centrum Medycznego Kształcenia Podyplomowego, Otwock

Sponsors

Collaborators (1)

KCRI
All Listed Sponsors
collaborator

KCRI

OTHER

lead

Medical Inventi S.A.

INDUSTRY

NCT07209033 - FlexiOss® - Efficacy, Safety and Long-term (Radiological and Clinical) Outcomes During Comprehensive Care Continuum of Implanted Biocomposite for Bone Regeneration. | Biotech Hunter | Biotech Hunter